Statement from ARMI Board of Directors

The ARMI Board of Directors is aware of recent disclosures from the DOJ involving founder and board member, Dean Kamen. The Board accepts Dean’s recusal from all Board activities while an independent review is conducted, and ARMI will sustain its focus on its mission to transform the future of human health.

More News

ARMI

Initiatives

Learn more about work underway to build the biofabrication ecosystem and accelerate the science of regenerative medicine.